[Consultation after cerebral infarction or intracerebral hematoma].
Hypertension is the principal risk factor for cerebral infarctions and intracerebral hematoma. The brain is the principal target of hypertension. The brain is the principal target of antihypertensive drugs. Controlling blood pressure and stopping smoking reduces the risk of cerebral infarction by 40%. Objectives of a consultation after cerebral infarction or intracerebral hematoma: validate diagnosis and cause, identify risk factors for recurrent cerebral infarction but also for myocardial infarction and lower limb arterial disease, begin treatment of the risk factors for recurrence, begin prevention of atherothrombotic complications and embolic heart disease, identify complications of cerebral infarction and intracerebral hematoma.
Benatru
Isabelle
I
Service de neurologie, Réseau Bourgogne-AVC (URCAM-ARH), CHU, Dijon.
Contegal
Fabienne
F
Rouaud
Olivier
O
Caillier
Marie
M
Menassa
Michael
M
Osseby
Guy-Victor
GV
Vernet
Bernard
B
Durier
Jérôme
J
Fromont
Agnès
A
Moreau
Thibault
T
Giroud
Maurice
M
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000150:complications; D002543:Cerebral Hemorrhage / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D002544:Cerebral Infarction / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D003276:Contraceptives, Oral / Q000009:adverse effects; D048909:Diabetes Complications; D015444:Exercise; D005260:Female; D006406:Hematoma / Q000150:complications / Q000517:prevention & control; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D007239:Infections / Q000150:complications; D007866:Leg / Q000098:blood supply; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control; D009747:Nutritional Physiological Phenomena; D009765:Obesity / Q000150:complications / Q000628:therapy; D012008:Recurrence; D012306:Risk; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation; D013997:Time Factors; D015431:Weight Loss
D000959:Antihypertensive Agents; D003276:Contraceptives, Oral